Literature DB >> 17557963

Bimodal population or pathologist artifact?

David L Rimm, Jennifer M Giltnane, Christopher Moeder, Malini Harigopal, Gina G Chung, Robert L Camp, Barbara Burtness.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17557963     DOI： 10.1200/JCO.2006.07.7537

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

1.  Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome.

Authors:  Malini Harigopal; William E Barlow; Greg Tedeschi; Peggy L Porter; I-Tien Yeh; Charles Haskell; Robert Livingston; Gabriel N Hortobagyi; George Sledge; Charles Shapiro; James N Ingle; David L Rimm; Daniel F Hayes
Journal:  Am J Pathol       Date:  2010-02-11       Impact factor: 4.307

2.  Bimodal gene expression and biomarker discovery.

Authors:  Adam Ertel
Journal:  Cancer Inform       Date:  2010-02-04

3.  Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring.

Authors:  Anthony E Rizzardi; Arthur T Johnson; Rachel Isaksson Vogel; Stefan E Pambuccian; Jonathan Henriksen; Amy Pn Skubitz; Gregory J Metzger; Stephen C Schmechel
Journal:  Diagn Pathol       Date:  2012-06-20       Impact factor: 2.644

4.  Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer.

Authors:  Anthony E Rizzardi; Xiaotun Zhang; Rachel Isaksson Vogel; Suzanne Kolb; Milan S Geybels; Yuet-Kin Leung; Jonathan C Henriksen; Shuk-Mei Ho; Julianna Kwak; Janet L Stanford; Stephen C Schmechel
Journal:  Diagn Pathol       Date:  2016-07-11       Impact factor: 2.644

5.  An Image Analysis Solution For Quantification and Determination of Immunohistochemistry Staining Reproducibility.

Authors:  Elizabeth A Chlipala; Christine M Bendzinski; Charlie Dorner; Raili Sartan; Karen Copeland; Roger Pearce; Faye Doherty; Brad Bolon
Journal:  Appl Immunohistochem Mol Morphol       Date:  2020-07

6.  Bimodal age distribution at diagnosis in breast cancer persists across molecular and genomic classifications.

Authors:  Emma H Allott; Yue Shan; Mengjie Chen; Xuezheng Sun; Susana Garcia-Recio; Erin L Kirk; Andrew F Olshan; Joseph Geradts; H Shelton Earp; Lisa A Carey; Charles M Perou; Ruth M Pfeiffer; William F Anderson; Melissa A Troester
Journal:  Breast Cancer Res Treat       Date:  2019-09-18       Impact factor: 4.872

7.  Astronomical algorithms for automated analysis of tissue protein expression in breast cancer.

Authors:  H R Ali; M Irwin; L Morris; S-J Dawson; F M Blows; E Provenzano; B Mahler-Araujo; P D Pharoah; N A Walton; J D Brenton; C Caldas
Journal:  Br J Cancer       Date:  2013-01-17       Impact factor: 7.640

8.  Vascularity of primary and metastatic renal cell carcinoma specimens.

Authors:  Saadia A Aziz; Joshua Sznol; Adebowale Adeniran; John W Colberg; Robert L Camp; Harriet M Kluger
Journal:  J Transl Med       Date:  2013-01-14       Impact factor: 5.531

9.  A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.

Authors:  Arvydas Laurinavicius; Benoit Plancoulaine; Aida Laurinaviciene; Paulette Herlin; Raimundas Meskauskas; Indra Baltrusaityte; Justinas Besusparis; Darius Dasevicius; Nicolas Elie; Yasir Iqbal; Catherine Bor
Journal:  Breast Cancer Res       Date:  2014       Impact factor: 6.466

10.  Association between low estrogen receptor positive breast cancer and staining performance.

Authors:  Dennis Caruana; Wei Wei; Sandra Martinez-Morilla; David L Rimm; Emily S Reisenbichler
Journal:  NPJ Breast Cancer       Date:  2020-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.